The UC San Diego Center for Neuromodulation combines scientifically rigorous analysis, clinical innovation, and multidisciplinary collaboration to investigate  repetitive transcranial magnetic stimulation (rTMS). We aim to decipher underlying mechanisms of transcranial magnetic stimulation, and, in so doing, enable the translation of these findings into effective treatments for an array of neurocognitive disorders and related illnesses. 

Our Mission

​Our mission is to investigate next-generation technologies in rTMS therapy and EEG analysis, test their efficacy for clinical practice, and make them available to physicians and their patients. The Center for Neuromodulation combines quantitative neurocognitive science and clinical trial assessment to develop groundbreaking rTMS technology that stands to forge a path towards new and better treatment technologies for the brain.

Center for Neuromodulation researchers aim to gain a deep understanding of the electrical and physiological underpinnings of human brainwaves and develop a theoretical framework to model how rTMS treatment affects them. Discoveries made by our basic researchers are synchronized with our clinical investigations, which formally evaluate rTMS as a novel, low-risk therapy for a number of neurocognitive disorders where no other robust therapy options currently exist.

What is rTMS?

The UC San Diego Center for Neuromodulation studies rTMS and other related technologies. rTMS, or repetitive transcranial magnetic stimulation, is a qEEG-guided technique which uses a low electrical current to modulate the brain's intrinsic activity.